<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 230 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page229.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=230">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 230 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 230</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=230"><img src="../thumb/230.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>194 / 2020-04                                                            Dermatologicals - 14.6

                                                                 WITH ALDARA YOUR PATIENTS
                                                                 HAVE EFFECTIVE SUSTAINED
                                   ACTINIC /    SUPERFICIAL    EXTERNAL
                                    SOLAR    BASAL CELL    GENITAL   CLEARANCE FOR AK, sBCC
                                   KERATOSIS  CARCINOMA  WARTS   AND EGW 1-4

   Dosage: Commenc.on 5th day of menstr.cycle with 1 tab taken   Side effects: V.common: Skin irritat., dry skin, urticar., peel. Com-  depress., fluid retent., risk of thrombos., oligomenorrh., amenorrh.,
   from appropr. marked blister, contin. with 1 tab dly.till tab. mark.with   mon: GI disords., seborrh. Post market: Folliculit., eye pain, pseu-  hypercholest., famil.hyperlipoprot.
   no.15. Foll. above regim.every 28 days. Length of treatm. determ.  domembran. colit., abdom.pain, contact dermatit.  Interactions: Anti-epilep.agents, antibiot., barbit., rifampicin decr.
   by severity & respons.       Warnings and special precautions: Investig. prolong./signif.   effic.insulin & other hypoglyaem. requirem.may change.
   Contraindications: Pregn.& lact., liv.dis., hist. of persist.itch/ jaund./  diarrh.& discont.ther.if necess., topic.absorpt.occurs, avoid mouth
   herpes dur.prev.pregn., Dubin Johnson syndr., Rotor syndr., wast.dis.,   & sensitive surf./ abrad.skin & muc.membr., atopic pts., safety in   DIFFERIN, Galderma [P/S]
   depress., prev./exist.liv.tumours or thromboembol. process., diab.with   pregn.& lactat.not est., report.in breast milk aft. oral & parenter.admin.  Adapalene.
   vascul. changes, sickle cell anaem., admin.bef.conclus.of puberty.  Interactions: Antiperistalt.meds.poss.prolong/ aggrav.colit., system.  Indications: Acne vulgaris where comedones, papules & pus-
   Side effects: Body weight & libido chang., breast tens., tiredn., rest-  admin.enhanc.neuromusc. block act.  tules predominate.
   lessn., depress.moods, liver funct. disturbs., reduc.adren.cortex funct.   (S3) GEL. 29/13.12/0606. 1 mg/g.
   with high dos.treatm., imp.concent.  DAPTA, Litha [P/S]    827215-002: 30 g, R274,45
   Special precautions: Concurr.contracept., reg. check of liv.funct.,   Adapalene.  (S3) CREAM. 32/13.12/0476. 1 mg/g.
   monit.carbohydr.metabol.of diab. CV dis., ischaem.heart dis., cer-  Indications: Acne vulgaris where comedones, papules & pustules   863939-007: 30 g, R274,45
   ebrovasc.dis. & hypertens., consult Dr.if bleed.fails to occur aft.   predomin.in pts. 12 yrs.& old.  Dosage: Apply once dly.to affect.area bef.retir.& aft.wash.
   28 day cycle., bear in mind that sex.steroids can promote growth   (S3) GEL. 1 mg/g. 46/13.11/0163  Contra-indications: Childr.und.12 yrs., sev.acne, concom.retinoids/
   of cert.horm.depend.tiss.& tumours., consid.different.diagn.of liv.  721708-001: 30 g, R192,63  meds with similar act.
   tumour if sev.upper abdom.compl., liv.enlargem./signs of intra-ab-  (S3) CREAM. 1 mg/g. 46/13.11/0162  Side-effects: Skin irritat., dry skin, burn.sensat., erythema, contact
   domin.haemorrh.occur.        721707-001: 30 g, R192,63     dermatit., skin discomf., sunburn, prurit., skin exfoliat., acne flare, skin
                                Dosage: Apply once dly.to affect.area bef.retir.& aft.wash. Improvem.  pain & swell., eyelid irrit./-erythema/-prurit/-swell.
   BENZAC AC 5, Galderma [P/S]  expect.aft.4-8 wks ther. & furth.with contin.use. Treatm.to be eval.if   Special precautions: Allerg.reacts.may arise aft.treatm.completed,
   Benzoyl peroxide.            no improvem.aft. 8-12 wks.    not to be used in pregn.& lactat., tetratogen.shown in anim.with oral
   Indications: Acne vulgaris.  Side effects: Freq: Skin burn./sting.sensat., ythema, skin dryn./ ir-  admin., discont.in case of sev.irritat., do not apply to broken skin/large
   (S0) GEL. [P/S] X/13.12/133. 5 g/100 g.  ritat. Less freq: Acne flares, cont. dermatit., skin discomf./-exfoliat.,   surf.areas esp.in women of childbear.age not on adeq.contracept.,
   807842-029: 15 g, R77,05     photosens., prurit.           other retinoids/ meds.with simil.mode of act.not to be used concur.,
   807842-028: 40 g, R196,29    Warnings and special precautions: Reduc. dos.or discont.in   eff.of rep.expos.to sun & UV irradiat. not est.theref.avoid, poss ad-
   Dosage: Apply 1-2xdly.to affect.areas aft cleans.  case of sev.irrit., avoid contact with mouth/angl.of nose/other mu-  dit.irrit.effs.with concom. peel.agents/irrit.prod.& astringents, use
   (S0) WASH. [P/S] 30/13.12/0044. 5 g/100 g.  cous surf., sev.acne/acne to large body areas, adeq. contracept. in   of other cutan.anti-acne treatm. eg erythromycin, benzoyl perox.
   856924-008: 100 g, R194,09   women of child bear.potent., applic. to eczemat./sunburnt/abrad.skin,   may be used in morn.
   Dosage: Apply 1-2xdly.to affect.areas, rub gently & leave on skin   avoid excess.UV /sunlight expos., poss.delay.allerg.reacts., safety &
   x30secs.bef.rins.            effic.in pregn. /childr.und.12 yrs.not est., breast feeding not recomm,   DIVA 35, Unicorn [P/S]
   Side effects: Allerg.contact dermatit.& dryn.              21 tabs: cyproterone acetate 2 mg, ethinyl-oestradiol 35 µg. 7 pla-
   Special precautions: Safety dur.pregn., lactat. & use in childr.not   avoid applicat.to breast if breast feed., use only non-comedogen.&   cebo tabs.
   est., discont.in case of sev.irrit.  non-astring.concom.cosmet.  Indications: Sev.androgen-depend.acne, androg. alopec.& mild
   Warnings: Avoid contact with eyes, eyelids, lips & muc. membr.,   Interactions: Avoid other concom.retinoids/ agents with simil.  hirsutism in women, oral contracept. where anti-androg.ther.reqd.
   poss.bleach./skin discolourat.if in cont.with any materials, poss.trans.  mode of act./topic.preps.poss. caus.irrit., apply topic.antibact./ben-  (S4) TABS, 38/21.8.2/0055
   skin discolourat. if used with PABA-contain.sunscreens.  zoyl perox.in morn.& Dapta at night, eff.of rep.expos.to sun & UV ir-  707875-001: 28, 1 mnth.cal.pack, R99,08
                                radiat.not est.theref.avoid,  Dosage: 1 tab.at same time dly.from 1st day of menstr. cycle.
   CLINDOXYL, GSK [P/S] &                                     Contra-indications: Pregn.& lactat., mod.imp. liv.funct., cholestas.,
   Clindamycin 1 g, anhydr.benzoyl peroxide 5 g/100 g  DERIVA, Glenmark [P/S]
   Indications: Acne vulgaris esp.inflamm.les.in adolesc.& adults.  Adapalene.  Dubin-Johns.or Rotor syndr., hepat.adenomas, oestrog.depend. neo-
                                                              plasms eg breast or endometr.Ca, CV dis. incl.prev./exist.arter./ven.
   (S4) GEL, 42/13.11/0441      Indications: Acne vulgaris of face/chest & back where comedones,
   719260-001: 25 g, R258,36    papules & pustules predominat.  thrombot.or embol. process. or predispos.condits., lipid metabol.
                                                              disturbs., undiag.vag.bleed., cholestat.jaund., chorea, herpes, pem-
   Dosage: Wash affect.skin area, rinse & pat dry. Apply gel once dly.in   (S3) GEL. 44/13.11/0766. 1 mg/g.
   even. In some cases 4-6 wks may be requir.bef.full therap.eff. Treatm.  720276-001: 30 g, R215,80  phigoid gestationis/ deteriorat. otoscleros., sev./foc.migraine, cer-
                                                              ebrovasc.condit., advanc.diab.mellit.with vasc. changes, sickle-cell
   not to exceed more than 12 wks.contin.use.  Dosage: Apply once dly.aft.wash to affect.area bef.retir. Treatm.
   Contraindications: Safety in pregn.& lactat.not est., lincomycin   may be resum.in the event of tempor.discont./reduc.freq. if pt.judg.  dis., porphyr., men, childr.
                                                              Side-effects: Hepat.Ca, thrombos., weight gain, depress., N&V, alt.
   hypersens., safety & effic.in childr. und. 12 yrs.not est.  to tol.treatm.
   Side effects: Erythema/peel./dryn./prurit.at applic. site, paraesthes.,   Contraindications: Neonates & childr.und.12 yrs., sev.acne, safety   liv.funct., hepatit., jaund., hepatomegaly, hepat.fail., gall bladd.dis., al-
   acne worsen., cont. dermatit., burn., diarrh., isolat.pseudomembr.co-  in pregn.& lactat.not est.,   opec., photosens., allerg.rash, breast tendern., vag.candidias., throm-
   lit., resist.with longt.use, allerg.reacts.  Side effects: Skin irrit., erythema, dryn., scal., prurit., burn., photo-  boembol.disords., thrombosis, reduc.gluc.tol., lipid metabol. changes,
   Warnings and special precautions: Avoid mouth/ eyes/skin/   sens., contact dermat., sting.& warm feel.  appetite changes, mood/ment./libido changes, dizzin., headache,
   mucous membr./abrad.or eczemat. skin, minim.sun/sun lamp expos.,   Special precautions: Discont.in case of sev. irritat/reduc.freq./  migraine, contact lens intol., fluid retent., hypertens., GI disturbs.,
   atop. pts., sens.skin, reduc.applic.freq.in case of excess. dryn./irrit.,   discont.tempor., avoid contact with eyes/muc.membr./broken or   chloasma, melisma, haemorrhag.erupt., cervic. secret.changes,
   lincomycin/erythromycin cross-resist., avoid other concom.topic.acne   eczemat.skin, sev.acne cover.large areas of body, not to be used in   incr.cerv.& breast Ca risk, menstr. irregular., post treatm.anovulat.
   preps.cont.Vit.A, potent.synerg.betw.clindamycin & gentamycin, con-  women of childbear.age unless effect. contracept. pract., other con-  Special precautions: Depress.hist., gall bladd. dis., condits.influ-
   com.topic.antibiot./abrasiv./alcoh.cont.prod. &/astring.  com.retinoids/ meds. with simil.mode of act., safety of rep.expos.  enc.by fluid retent., high BP, varicos.veins., phlebit.hist., otoscleros.,
   See also MDR page 359.       to sun & UV irradiat.not est, poss addit.irrit.effs.with concom. peel.  multipl. scleros., epilep., tetanus, chorea min., asthma, discont.4-6
                                                              wks. bef.surg.assoc.with incr. thrombo-embol.risk or prolong.immo-
   CYCLIMYCIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]  agents/irrit.prod./astringents, use of other cutan.anti-acne treatm.  bilisat., discont.immed.in case of first sign of thrombo-embol.dis-
                                eg erythromycin, benzoyl perox.may be used in morn., birth defects.
   Minocycline HCl equiv.to minocycline  report.with topic.retinoid expos.dur.pregn.  ords./unusual.sev.prolong.headache / sudd.vis./hear./percept.dis-
   Indications: Acne-adjunct.                                 turbs./collapse,/S&S of cerebrovasc.dis./hepatit./jaund./gen.itch./
   (S4) CAPS. W/20.1.1/0442, 0443  DIANE-35, Bayer [P/S]      liv. enlargem./sev.upper abdom. pain/sev.depress./ signific.incr.BP/
   788287-001: 50 mg, 60, R229,24  21 beige tabs: Cyproterone acetate 2 mg, ethinylestradiol 0,035 mg.   exacerbat.of condits.known to poss.deterior.dur.OC ther./pregn., past
   788295-012: 100 mg, 100, R1 118,40  7 placebo tabs.        oligomenorrh. & amenorrh., addit.non hormon. contracept.methods
   Dosage: Acne: Init. 50-100 mg 2xdly. Maint: 50 mg 2xdly.  Indications: Androgen depend.acne, androgen depend.alopec.,   when effic.at risk, surg., investig.heavy inter menstrual bleed., incr.
   Contraindications: Pregn.& lactat., childr.und.12 yrs, potent.   hirsut., contracept.  incid. circulat.dis., fam.hist of arter.dis., hypercholesterolaem., fa-
   hepatotox.medic.             (S4) TABS, V/21.8.2/300       milial hyperlipoproteinaem., diab.mellit., obesity, migraine, benign
   Side effects: GI disturbs., non-suscept.organ overgrowth, tooth dis-  825859-018: 28, 1 mnth.cal.pack, R191,23  & malign.liv.tumours observ., consid.liv.tumour in different.diagnos.
   col., enamel hypoplas.& retard.bone growth in childr.und.12/foetus,   Dosage: 1 tab.at same time dly.from 1st day of menstr. cycle.  in pres. of sev.upper abdom.complaints/liv.enlargem./signs of intra
   incr.IC-press & bulg. fontanelle in infts., bld.dyscras., vit. defic., allerg.   Contraindications: Pregn., lactat., disturb.of liv.funct., cholestat.  abdom.haemorrh.
   reacts., photosens., poss.neg.N2 bal. in elderly.  jaund., Dubin-Johnson syndr., Rotor syndr., prev./exist.liv.tumours,   Drug interactions: Reduc.plasma lev.with antibiot., enzyme in-
   Special precautions: Imp.liv.funct.  thrombo-embol. process., sev.migraine, cerebro-vasc. insuff., sickle-  duc.eg.anti-epilept.agents/ griseofulvin /barbitur./phenylbutazone
   Drug interactions: Poss.reduc.anticoag.dos., Ca, Mg, Al & iron salts   cell anaem., breast/endometr.Ca., undiag. vag.bleed., sev.diabet.,   & rifampic. imp.act., effic.of anticoags./ antidepress./ anti-diabet./
   decr.absorpt., poss.antagon.in act. with concom.penicill.  lipometabol. disturb., hist.of herpes/itch./jaund.of pregn., otoscleros.  anti-hypertens./ß-blocks. & diurets.reduc., theophyll.& cyclospor.
   DALACIN T, Pfizer [P/S]      with deteriorat.in prev.pregn.  plasma conc.incr., large supplem.Vit.C incr. ethinyloestradiol ser.lev.
   Clindamycin phosphate equiv.to clindamycin base   Side effects: Coron.& ven.thrombos., CVA’s, hypertens., prolong.  DOXYCYCLINE BIOTECH 100 MG, Biotech Laboratories (Pty) Ltd
   Indications: Acne vulgaris.  amenorrh., N&V, headache, mood chang., chang.in libido, weight   See Section 18.4
   (S4) SOL, [P/S] P/20.1.6/63. 10 mg/ml.  gain, skin pigmentat., poor contact lens toler., gall bladd. dis., vag.
   835757-005: 30 ml, R143,36   candidias., GI-irrit., fluid retent., breast tightn.& tendern., benign &   DOXYCYL, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
   (S4) LOT, [P/S] Y/20.1.6/326. 10 mg/ml.  malig.liv.tumours.  Doxycycline HCl equiv.to doxycycline
   828718-008: 30 ml, R168,25   Special precautions: Rule out clott.syst. disturbs., bear in mind   Indications: Acne.
   Dosage: Apply thin.to affect.area 2xdly.  sex.steroids can promote growth of cert.horm.depend.tiss.& tu-  (S4) CAPS. 27/20.1.1/0495.
   Contraindications: Lincomycin/clindamycin sens., antibiot.assoc.  mours, diabet., hypertens., varicose veins, phlebit.hist., otoscleros.,   808407-007: 50 mg, 30, R81,64
   colit./ulcerat.colit./Crohn’s dis.  multiple scleros., epilep., porphyr., tetany, chorea minor, asthma,   Dosage: 1 cap 2xdly with adeq.fluid
     References: 1. Krawtchenko N, et al. Br J Dermatol 2007; 157(Suppl.2):34-40. 2. Stockfleth E et al. Arch Dermatol/Vol 140, Dec 2004:1542. 3. Gollnick H, et al. Eur J Dermatol 2005; 15(5):374-381. 4. Edwards L, et al. Arch Dermatol 1998; 134:25-30.
     Scheduling status: S4 Proprietary name and dosage form: ALDARA Cream. Composition: Each 2,0 g cream pump contains 5 % Imiquimod (100 mg). ALDARA Cream Sachet. Composition: Each 250 mg cream sachet
     contains 5 % Imiquimod (12,5 mg). Preservatives: Methyl hydroxybenzoate 0.2 % m/m, Propyl hydroxybenzoate 0.02 % m/m, Benzyl alcohol 2 % m/m. Pharmacological classification: A 34 Other. Indications: ALDARA
     Cream is indicated for the topical treatment of superficial basal cell carcinoma (sBCC), and of external genital/perianal warts (condyloma acuminata) and clinically typical, non hyperkeratotic, nonhypertrophic actinic keratosis
     (AKs) on the face or scalp in adult patients. Registration number: 32/34/0541. Name and business address of the holder of the certificate of registration: iNova Pharmaceuticals (Pty) Ltd,. Co. Reg. No. 1952/001640/07,
     15e Riley Road, Bedfordview. Tel. No. 011 087 0000. www.inovapharma.co.za. For full prescribing information, refer to the package insert as approved by the SAHPRA (South African Health Products Regulatory Authority).
     Further information is available on request from iNova Pharmaceuticals. IN3635/20</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page229.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page225.html">225</a>&nbsp;&nbsp;&nbsp;<a href="page226.html">226</a>&nbsp;&nbsp;&nbsp;<a href="page227.html">227</a>&nbsp;&nbsp;&nbsp;<a href="page228.html">228</a>&nbsp;&nbsp;&nbsp;<a href="page229.html">229</a>&nbsp;&nbsp;&nbsp;<a href="page230.html">230</a>&nbsp;&nbsp;&nbsp;<a href="page231.html">231</a>&nbsp;&nbsp;&nbsp;<a href="page232.html">232</a>&nbsp;&nbsp;&nbsp;<a href="page233.html">233</a>&nbsp;&nbsp;&nbsp;<a href="page234.html">234</a>&nbsp;&nbsp;&nbsp;<a href="page235.html">235</a>
             </td>
             <td width="35%"><a href="page231.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page231.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
